CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −1,879 | $173.74 | $326K | 13,119 |
| 2025-03-04 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +5,674 | $173.74 | $986K | 23,430 |
| 2025-03-04 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −2,280 | $173.74 | $396K | 21,150 |
| 2025-03-04 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale 10b5-1 | −592 | $175.79 | $104K | 38,117 |
| 2025-03-04 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award 10b5-1 | +8,549 | $173.74 | $1.5M | 46,666 |
| 2025-03-04 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes 10b5-1 | −3,906 | $173.74 | $679K | 42,760 |
| 2025-03-04 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award | +5,317 | $173.74 | $924K | 11,300 |
| 2025-03-04 | DELANEY MARK E SVP & Chief Commercial Officer | Shares withheld for taxes | −1,823 | $173.74 | $317K | 9,477 |
| 2025-03-04 | SAMAD SAM Executive Vice President & CFO | Grant or award | +13,884 | $173.74 | $2.4M | 34,061 |
| 2025-03-04 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −7,684 | $173.74 | $1.3M | 26,377 |
| 2025-03-03 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −1,692 | $173.74 | $294K | 33,521 |
| 2025-03-03 | Doherty Catherine T. EVP, Regional Businesses | Shares withheld for taxes 10b5-1 | −394 | $173.74 | $68K | 68,784 |
| 2025-03-03 | Davis J. E. CEO and President | Shares withheld for taxes | −1,662 | $173.74 | $289K | 136,553 |
| 2025-03-03 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −992 | $173.74 | $172K | 10,564 |
| 2025-03-03 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −106 | $173.74 | $18K | 17,756 |
| 2025-03-03 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes 10b5-1 | −322 | $173.74 | $56K | 38,709 |
| 2025-02-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale 10b5-1 | −528 | $172.61 | $91K | 39,031 |
| 2025-02-27 | Doherty Catherine T. EVP, Regional Businesses | Sale 10b5-1 | −824 | $172.61 | $142K | 69,178 |
| 2025-02-26 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −869 | $171.75 | $149K | 20,177 |
| 2025-02-26 | Davis J. E. CEO and President | Shares withheld for taxes | −2,966 | $171.75 | $509K | 138,215 |
Page 14 of 21 · 409 trades